Charles Schwab Corporation
Here are some key analyst takeaways:
- Goldman Sachs analyst Alexander Blostein reiterated a Buy rating, while raising the price target from $110 to $114.
- Keefe, Bruyette & Woods analyst Kyle Voigt maintained an Outperform rating, while lifting the price target from $109 to $111.
The third-quarter results were supported by a significant increase in securities lending revenues, which is unlikely to recur, the analyst stated. He added, however, that NII is likely to continue to grow.
Blostein further commented that there is more room for the stock to run, as Charles Schwab's earnings growth acceleration is "firmly underway" and on track to continue through 2026 and 2027, driven by:
- An NII CAGR of around 10%
- Newer client monetization opportunities in the alts platform
- The upcoming crypto platform launch set to contribute more meaningfully
- An acceleration of capital returns backed by share repurchases of $2.7 billion
Charles Schwab has continued to witness "strong engagement from clients" so far in October, the analyst stated. The company repurchased around $2.7 billion worth of shares in the quarter, higher than estimates of $1.4 billion, he commented.
"We continue to believe consensus is underestimating the company's capacity to return capital over the coming years," Voigt further wrote.
SCHW Price Action: Charles Schwab shares were up 0.70% at $94.06 at the time of publication on Friday, according to Benzinga Pro data.
